Exercise prescription for autistic populations

M. Lochbaum,D. Crews

DOI: https://doi.org/10.1007/BF02179295

1995-06-01

Journal of Autism and Developmental Disorders

Abstract:

What problem does this paper attempt to address?

Synthesis and Antitumor Activity of Hederagenin Derivatives

Huang Xing,Zhang Changhao,Deng Hao,Shen Qingkun,Guo Hongyan,Quan Zheshan,Li Zhiyong,Jin Lili

DOI: https://doi.org/10.6023/cjoc202204021

2022-01-01

Abstract:Using hederagenin as lead compound, three series of novel hederagenin derivatives containing various heterocycles were designed and synthesized. Their structures were characterized by H-1 NMR, C-13 NMR and HRMS. The in vitro antitumor activities of these compounds on human non-small cell lung cancer cells (A549), human breast cancer cells (MCF-7), human colon cancer cells (HCT116), human colon cancer cells (SW620), human hepatoma cells (HepG-2) and human hepatoma cells (BEL7402) were evaluated by thiazolyl blue (MTT) method. The experimental results showed that (3 beta,4 alpha)-3,23-dihydroxy-olean12-ene-28-acid-(1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl) methyl ester (A5) had the strongest anti-proliferative activity (IC50=2.05 mu mol/L) on HCT116 cells. Western blotting experiments showed that compound A5 may exert its antitumor activity through NF-kappa B signaling pathway.
Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Huan-yu Ren,Xiu-wen Tang

DOI: https://doi.org/10.3785/j.issn.1008-9292.2011.05.008

2011-01-01

Abstract:OBJECTIVE:To investigate the antitumor effect of apigenin on human lung cancer cells.METHODS:The anti-proliferation and sensitization effects of apigenin on human lung cancer cells was accessed by counting cells after Trypan blue staining and MTS assay.RESULTS:(1) Apigenin significantly suppressed the proliferation of four types of human lung cancer cells (A549:P=0.041, H460:P=0.050, LTEP-a2:P=0.039, H292:P=0.016); (2) Apigenin significantly increased the susceptibility of human lung cancer cells to antitumor drugs (P<0.05 or P<0.01) in a synergistic way (almost all of the combination index values are less than 1).CONCLUSION:Apigenin widely inhibits cell proliferation of various lung cancer cell lines in a dose-dependent manner and the combination treatment of apigenin and antitumor drugs is very effective in human lung cancer cells, and Nrf2-ARE pathway may contribute to the mechanism.
Hederagenin promotes lung cancer cell death by activating CHAC1-dependent ferroptosis pathway

Jiayan Lu,Qixia Guo,Hui Zhao,Hua Liu

DOI: https://doi.org/10.1016/j.bbrc.2024.150085

2024-07-23

Abstract:Lung cancer poses a significant threat globally, especially in China. This puts higher demands on the treatment methods and drugs for lung cancer. Natural plants provide valuable resources for the development of anti-cancer drugs. Hederagenin (Hed) is a triterpenoid compound extracted from ivy leaves and has anti-tumor activity against multifarious cancers, including lung cancer. However, the regulatory mechanism of Hed in lung cancer remains unclear. In this study, we used Hed to treat lung cancer cells, and observed the effect of Hed on cell proliferation (including CCK-8 and colony formation experiments), apoptosis (including flow cytometry and apoptosis gene detection (BAX and Bcl-2)). The results showed that Hed induced lung cancer cell death (inhibiting proliferation and promoting apoptosis). Next, we performed bioinformatics analysis of the expression profile GSE186218 and found that Hed treatment significantly increased the expression of CHAC1 gene. CHAC1 is a ferroptosis-inducing gene. RT-qPCR detection of lung cancer clinical tissues and related cell lines also showed that CHAC1 was lowly expressed in lung cancer. Therefore, we knocked down and overexpressed CHAC1 in lung cancer cells, respectively. Subsequently, cell phenotype experiments showed that down-regulating CHAC1 expression inhibited lung cancer cell death (promoting proliferation and inhibiting apoptosis); on the contrary, up-regulating CHAC1 expression promoted lung cancer cell death. To further verify that Hed exerts anti-tumor effects in lung cancer by promoting CHAC1 expression, we performed functional rescue experiments. The results showed that down-regulating CHAC1 expression reversed the promoting effect of Hed on lung cancer cell death. Mechanistically, in vitro and in vivo experiments jointly demonstrated that Hed exerts anti-cancer effects by promoting CHAC1-induced ferroptosis. In summary, our study further enriches the regulatory mechanism of Hed in lung cancer.
Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Qian Zheng,Wei-wei Liu,Bin Li,Hui-jie Chen,Wen-shan Zhu,Guang-xiao Yang,Ming-jie Chen,Guang-yuan He

DOI: https://doi.org/10.1007/s11596-014-1305-1

2014-01-01

Abstract:Icaritin, a prenylflavonoid derivative from Epimedium Genus, has been shown to exhibit many pharmacological and biological activities. However, the function and the underlying mechanisms of icaritin in human non-small cell lung cancer have not been fully elucidated. The purpose of this study was to investigate the anticancer effects of icaritin on A549 cells and explore the underlying molecular mechanism. The cell viability after icaritin treatment was tested by MTT assay. The cell cycle distribution, apoptosis and reactive oxygen species (ROS) levels were analyzed by flow cytometry. The mRNA and protein expression levels of the genes involved in proliferation and apoptosis were respectively detected by RT-PCR and Western blotting. The results demonstrated that icaritin induced cell cycle arrest at S phase, and down-regulated the expression levels of S regulatory proteins such as Cyclin A and CDK2. Icaritin also induced cell apoptosis characterized by positive Hoechst 33258 staining, accumulation of the Annexin V-positive cells, increased ROS level and alteration in Bcl-2 family proteins expression. Moreover, icaritin induced sustained phosphorylation of ERK and p38 MAPK. These findings suggested that icaritin might be a new potent inhibitor by inducing S phase arrest and apoptosis in human lung carcinoma A549 cells.
Ethyl acetate extract from Selaginella doederleinii Hieron inhibits the growth of human lung cancer cells A549 via caspase-dependent apoptosis pathway

Yuxia Sui,Shaoguang Li,Peiying Shi,Youjia Wu,Yuxiang Li,Weiying Chen,Liying Huang,Hong Yao,XinHua Lin

DOI: https://doi.org/10.1016/j.jep.2016.06.029

2016-08-22

Abstract:Ethnopharmacological relevance: Selaginella doederleinii Hieron has been used as a folk medicine for the treatment of different cancers, especially for nasopharyngeal carcinoma, lung cancer and trophoblastic tumor in China. Previously, the ethyl acetate extract from S. doederleinii (SDEA extract) showed favorable anti-cancer potentials. However, the main chemical composition and anticancer mechanism of the SDEA extract were still not very clear. Until now, there are no reports available about the oral toxicity of the extract. Aim of study: The present study was to further elucidate the chemical composition and anti-lung cancer mechanism of the SDEA extract, and evaluate the acute oral toxicity of the extract. Materials and methods: The SDEA extract was separated and analysed by HPLC to disclose its main chemicals. The effects of the extract were then investigated in vitro on cell viability, apoptosis and cell cycle using fluorescence microscopy and flow cytometry, and the molecular mechanism against human lung cancer cells A549 was further studied by western blot assays. The in vivo anti-cancer effect of the extract was evaluated in A549 xenograft mice model by histochemical assay, and tumor growth, microvascular density (MVD) and Ki67 expression were also measured. In addition, acute oral toxicity test of the extract was executed in mice. Results: SDEA extract mainly contained eight biflavonoids. The extract caused the loss of mitochondrial membrane potential and induced cell apoptosis by upregulating Bax, downregulating Bcl-2, activating caspase-9 and caspase-3 and blocked the cell cycle in S phase. The extract reduced expression of antigen Ki67, decreased MVD, and significantly inhibited the tumor growth. The extract did not show apparent oral acute toxicity in healthy mice. Conclusion: The SDEA extract exerted anti-tumor effect through activating mitochondrial pathways and reducing Ki67 expression and MVD. Low oral acute toxicity suggested it a promising chemotherapy agent.
Alpha-Hederin induces incomplete autophagic injury in non-small cell lung cancer by interfering with the lysosomal acidification

Feng Jin,Xiaomin Jiang,Xiaochen Ni,Shilong Yu,Feng Wu,Xinlin Shi,Defang Mao,Haibo Wang,Qingtong Shi,Yanqing Liu,Qin Xu

DOI: https://doi.org/10.1038/s41598-024-63348-6

IF: 4.6

2024-06-12

Scientific Reports

Abstract:Lung cancer is the most common oncological disease worldwide, with non-small cell lung cancer accounting for approximately 85% of lung cancer cases. α-Hederin is a monodesmosidic triterpenoid saponin isolated from the leaves of Hedera helix L. or Nigella sativa and has been extensively studied for its antitumor activity against a variety of tumor cells. It has been suggested that α-Hederin is a potential regulator of autophagy and has high promise for application. However, the specific mechanism and characteristics of α-Hederin in regulating autophagy are not well understood. In this study, we confirmed the potential of α-Hederin application in lung cancer treatment and comprehensively explored the mechanism and characteristics of α-Hederin in regulating autophagy in lung cancer cells. Our results suggest that α-Hederin is an incomplete autophagy inducer that targets mTOR to activate the classical autophagic pathway, inhibits lysosomal acidification without significantly affecting the processes of autophagosome transport, lysosome biogenesis, autophagosome and lysosome fusion, and finally leads to impaired autophagic flux and triggers autophagic damage in NSCLC.

multidisciplinary sciences
Molecular mechanism of α-Hederin in tumor progression

Dandan Meng,Meng Ren,Maofeng Li,Min Wang,Wei Geng,Qingxin Shang

DOI: https://doi.org/10.1016/j.biopha.2023.116097

IF: 7.419

2024-01-02

Biomedicine & Pharmacotherapy

Abstract:α-Hederin is a monosaccharide pentacyclic triterpene saponin compound derived from the Chinese herb, Pulsatilla. It has garnered considerable attention for its anti-tumor, anti-inflammatory, and spasmolytic pharmacological activities. Given the rising incidence of cancer and the pronounced adverse reactions associated with chemotherapy drugs—which profoundly impact the quality of life for cancer patients—there is an immediate need for safe and effective antitumor agents. Traditional drugs and their anticancer effects have become a focal point of research in recent years. Studies indicate that α-Hederin can hinder tumor cell proliferation and impede the advancement of various cancers, including breast, lung, colorectal, and liver cancers. The principal mechanism behind its anti-tumor activity involves inhibiting tumor cell proliferation, facilitating tumor cell apoptosis, and arresting the cell cycle process. Current evidence suggests that α-Hederin can exert its anti-tumor properties through diverse mechanisms, positioning it as a promising agent in anti-tumor therapy. However, a comprehensive literature search revealed a gap in the comprehensive understanding of α-Hederin. This paper aims to review the available literature on the anti-tumor mechanisms of α-Hederin, hoping to provide valuable insights for the clinical treatment of malignant tumors and the innovation of novel anti-tumor medications.

pharmacology & pharmacy,medicine, research & experimental
Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

Minjian Kong,Junqiang Fan,Aiqiang Dong,Haifeng Cheng,Rongzhen Xu

DOI: https://doi.org/10.1093/abbs/gmq091

2010-01-01

Abstract:Polyphyllin I (PPI), a small molecular monomer extracted from Rhizoma of Paris polyphyllin, shows strong anticancer effects in previous study. Human lung adenocarcinoma A549 cells, human lung squamous cell carcinoma SK-MES-1 cells, and human lung large cell carcinoma H460 cells were cultured and then treated with PPI. Cell proliferation and apoptosis were measured by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, flow cytometry, western blot analysis, and DNA ladder. Athymic nude mice bearing tumors were injected with PPI, and tumor growth was recorded. Our results showed that PPI significantly inhibited the proliferation of three non-small cell lung cancer (NSCLC) cell lines, with the inhibitory concentrations (IC50) of 1.24, 2.40, and 2.33 mu g/ml for A549, H460, and SK-MES-1 cells, respectively. After being treated with 2.5 mu g/ml of PPI for 24 h, the apoptotic rate of A549 cells was 39.68%, which was remarkably higher than that of the control. Tumor growth was significantly inhibited in the PPI-treated group compared with the group treated with cisplatin (DDP) or PBS in the nude mice. PPI exhibits antitumor ability in NSCLC cells in vitro and in vivo, which might be related to the apoptosis induced by PPI.
Huaier shows anti‐cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF‐1α pathway

Xiangli Liu,Lidan Liu,Keyan Chen,Lei Sun,Wenya Li,Shuguang Zhang

DOI: https://doi.org/10.1111/jcmm.16215

2020-12-30

Journal of Cellular and Molecular Medicine

Abstract:Huaier has been verified to have anti‐cancer effects on many tumours. However, little information is available about the effects of Huaier on non‐small cell lung cancer (NSCLC). We sought to probe the anti‐cancer effects and related mechanisms of Huaier on lung cancer. A549 cells were pre‐treated with 2, 4 and 8 mg/mL Huaier at different time points. Thereafter, cell viability was analysed by CCK‐8 and the migration and invasion were detected by Scratch test and Transwell chamber migration assay. Moreover, ELISA, Western blot, shRNA transfection and RT‐PCR were conducted to discover the related gene and protein expressions of energy metabolism and phosphatidylinositol 3‐kinase (PI3K)/AKT/hypoxia‐inducible factor 1α (HIF‐1α) pathway. Furthermore, tumour xenografts were accomplished to inspect the anti‐cancer effects of Huaier. Our consequences suggested that Huaier considerably repressed cell viability and migration in a dose‐dependent way. In addition, Huaier statistically suppressed glycolysis, glucose transport and lactic acid (LA) accumulation. Besides, we detected that Huaier could inactivate the PI3K/AKT/HIF‐1α pathway. The in vivo data confirmed that Huaier obviously decreased tumour volume and tumour growth, reduced the glycolysis, glucose transport and HIF‐1α expression in the tumour‐bearing tissues. Our results suggested Huaier revealed anti‐tumour effects in both in vivo and in vitro possibly through PI3K/AKT/HIF‐1α pathway.

cell biology,medicine, research & experimental
Evaluation of the antiproliferative activity of 106 marine microbial metabolites against human lung cancer cells and potential antiproliferative mechanism of purpuride G

Hengju Ge,Muran Shi,Mingzhu Ma,Xiao-Yuan Lian,Zhizhen Zhang

DOI: https://doi.org/10.1016/j.bmcl.2021.127915

IF: 2.94

2021-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:A total of 106 marine microbial metabolites were evaluated for their antiproliferative activity against human lung cancer cells. Results showed that 23 compounds exhibited activity in inhibiting the proliferation of A549 and H157 cells with IC50 values ranging from 1.5 to 48.2 ?M. Pyrrospirone F, chrysophanol, physcion, and purpuride G are the four most active compounds with IC50 values of 1.5?7.3 ?M. Further investigation of purpuride G (a newly discovered sesquiterpene lactone) demonstrated its potent antiproliferative activity against six different lung cancer cells of A549, H157, H460, H1299, H1703, and PC9 with IC50 values of 2.1?3.3 ?M. The antiproliferative activity of purpuride G against cancer cells is related to block cell cycle, induce apoptosis through regulating the apoptotic proteins Bcl-2 and Bax, and inhibit glycolysis by downregulating two key glycolytic enzymes of hexokinase 2 and pyruvate kinase M2.
Rat brain aryl acylamidase: further characterization of multiple forms.

L. L. Hsu,A. Halaris,D. X. Freedman

DOI: https://doi.org/10.1016/0020-711X(82)90040-4

International Journal of Biochemistry

Abstract:
Dehydroevodiamine Targeting ACHE and ALDH3A1 Regulate Glycolytic Metabolism to Inhibit Hepatocellular Carcinoma Cell Apoptosis

Miaomiao Liu,Yuexi Cui,Zhoutao Xie,Yong Zheng,Hui Chen,Meng Wei,Kang Xu,Linghang Qu

DOI: https://doi.org/10.1177/1934578x231195153

IF: 1.496

2023-08-01

Natural Product Communications

Abstract:Dehydroevodiamine (DHE), a natural quinazoline alkaloid used in Chinese herbal medicine, exhibits promising antitumor properties in various cancers, including gastric cancer. Glycolysis is essential for tumor proliferation and survival. The antitumor effect of DHE on hepatoma cells (hepatocellular carcinoma, HCC) and the mechanism underlying the glycolytic regulation remain unclear. In this study, the cell viability, apoptosis rate, lactate release, and glucose uptake were evaluated in hepatoma cells treated with DHE. Cell metabolites were analyzed using GC-MS, and network pharmacology was employed to identify potential drug targets for DHE. Furthermore, the antiproliferative effect of DHE on liver cancer cells was examined by silencing the identified drug target. DHE promotes the apoptosis of Huh-7 and PLC cells. Cell metabonomics studies have shown that DHE primarily modulates the glycolysis/gluconeogenesis pathway. Simultaneously, DHE can inhibit the key enzymes HK2, PFKFB3, and LDHA of the glycolysis pathway, thus inhibiting glucose uptake and lactic acid production. Network pharmacological analysis identified ACHE and ALDH3A1 as the drug targets of DHE in liver cancer. Silencing ACHE and ALDH3A1 resulted in the loss of the apoptosis-promoting effect of DHE. Thus, DHE sensitizes aerobic glycolytic hepatoma cells to apoptosis by directly downregulating ACHE and ALDH3A1, leading to the inactivation of HK2, PFKFB3, and LDHA and suppression of aerobic glycolysis. DHE effectively inhibits the progression of liver cancer, primarily by reducing glucose metabolism, thereby inhibiting apoptosis of liver cancer cells. Therefore, DHE could be a promising agent for molecular-targeted cancer treatment strategies.

chemistry, medicinal,food science & technology
Echocardiographic frequency and severity of aortic regurgitation after ultrasonic aortic valve debridement for aortic stenosis in persons aged greater than 65 years.

P. McKenney,G. Balady,T. Ryan,R. Shemin

Abstract:
Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo

Qiong Li,Fu-Qiang Ren,Chun-Lei Yang,Li-Ming Zhou,Yan-You Liu,Jing Xiao,Ling Zhu,Zhen-Grong Wang

DOI: https://doi.org/10.7314/apjcp.2015.16.7.3035

Abstract:Background: Isorhamnetin (Iso), a novel and essential monomer derived from total flavones of Hippophae rhamnoides that has long been used as a traditional Chinese medicine for angina pectoris and acute myocardial infarction, has also shown a spectrum of antitumor activity. However, little is known about the mechanisms of action Iso on cancer cells. Objectives: To investigate the effects of Iso on A549 lung cancer cells and underlying mechanisms. Materials and methods: A549 cells were treated with 10~320 μg/ml Iso. Their morphological and cellular characteristics were assessed by light and electronic microscopy. Growth inhibition was analyzed by MTT, clonogenic and growth curve assays. Apoptotic characteristics of cells were determined by flow cytometry (FCM), DNA fragmentation, single cell gel electrophoresis (comet) assay, immunocytochemistry and terminal deoxynucleotidyl transferase nick end labeling (TUNEL) . Tumor models were setup by transplanting Lewis lung carcinoma cells into C57BL/6 mice, and the weights and sizes of tumors were measured. Results: Iso markedly inhibited the growth of A549 cells with induction of apoptotic changes. Iso at 20 μg/ml, could induce A549 cell apoptosis, up-regulate the expression of apoptosis genes Bax, Caspase-3 and P53, and down-regulate the expression of Bcl-2, cyclinD1 and PCNA protein. The tumors in tumor-bearing mice treated with Iso were significantly smaller than in the control group. The results of apoptosis-related genes, PCNA, cyclinD1 and other protein expression levels of transplanted Lewis cells were the same as those of A549 cells in vitro. Conclusions: Iso, a natural single compound isolated from total flavones, has antiproliferative activity against lung cancer in vitro and in vivo. Its mechanisms of action may involve apoptosis of cells induced by down-regulation of oncogenes and up-regulation of apoptotic genes.
[Cytokine combinations for in vivo and ex vivo expansion of hematopoietic progenitor cells].

K. Geissler,T. Wagner

Abstract:The critical role of hematopoietic progenitor cells (HPC) for the formation of mature blood cells is well established. Interleukin-3 (IL-3), stem cell factor (SCF), and flt3-ligand (FL) are potential candidates for expansion strategies due to their early acting and lineage-unspecific hematopoietic stimulation. In preclinical and clinical models IL-3, SCF, and FL induced in-vivo expansion of the progenitor cell pool has been shown to be associated with increased HPC-mobilization by G-CSF, reduction in the number of leukaphereses required to obtain adequate HPC-numbers and the potentiation of lineage-specific growth factors. Early acting cytokines are also crucial for ex-vivo expansion strategies and are here important partner molecules for IL-1, IL-6 and IL-10. In-vivo as well as ex-vivo expanded HPC are able to reconstitute hematopoiesis in patients following myeloablative chemoradiotherapy. Thus expanded HPC will be increasingly used for clinical purposes and facilitate therapeutic strategies which are currently limited by the problem of insufficient HPC-numbers.
18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells

Ying-Hua Luo,Cheng Wang,Wan-Ting Xu,Yu Zhang,Tong Zhang,Hui Xue,Yan-Nan Li,Zhong-Ren Fu,Ying Wang,Cheng-Hao Jin

DOI: https://doi.org/10.2147/ott.s322852

IF: 4

2021-10-22

OncoTargets and Therapy

Abstract:Ying-Hua Luo, 1, &ast Cheng Wang, 2, &ast Wan-Ting Xu, 3, &ast Yu Zhang, 3 Tong Zhang, 3 Hui Xue, 3 Yan-Nan Li, 3 Zhong-Ren Fu, 3 Ying Wang, 4 Cheng-Hao Jin 3– 5 1 Department of Grass Science, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 2 Pharmacy Department, Daqing Oilfield General Hospital, Daqing, 163001, People's Republic of China; 3 Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 4 College of Food Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 5 National Coarse Cereals Engineering Research Center, Daqing, 163319, People's Republic of China &astThese authors contributed equally to this work Correspondence: Cheng-Hao Jin; Ying Wang Email ; Background: 18β-glycyrrhetinic acid (18β-Gly), which is extracted from licorice root, has various pharmacological properties; however, its anti-cancer effects on lung cancer cells have not been fully established. Purpose: In this study, we investigated the underlying molecular mechanisms of 18β-Gly. Results: Our results showed that 18β-Gly had significant cytotoxic effects and no apparent side effects. 18β-Gly induced mitochondria-dependent apoptosis of A549 lung cancer cells. In addition, after treatment with 18β-Gly, intracellular reactive oxygen species (ROS) levels were significantly increased, and G2/M cell cycle arrest and inhibition of cell migration were induced via the mitogen-activated protein kinase (MAPK)/signal transducer and activator of transcription 3 (STAT3)/nuclear factor kappa (NF-κB) signaling pathways. After pretreatment with the ROS scavenger N-acetyl-L-cysteine or MAPK inhibitors, the expression levels of phosphorylated p38 (p-p38), phosphorylated c-Jun N-terminal kinase, inhibitor of nuclear factor kappa B, cleaved caspase-3 (cle-cas-3), cleaved poly (ADP ribose) polymerase (cle-PARP), p-p53, p27, p21, and E-cadherin were decreased; and levels of phosphorylated extracellular signal-regulated kinase, p-STAT3, NF-κB, Bcl-2, cyclin B1, cyclase-dependent kinase 1/2 (CDK1/2), N-cadherin, vimentin, and snail homolog 1 (SNAI 1) were increased. In addition, the percentage of cells in the G2/M phase was decreased, and inhibition of migration was reduced. Conclusion: In summary, 18β-Gly induced apoptosis and G2/M cell cycle arrest and inhibited migration via the ROS/MAPK/STAT3/NF-κB signaling pathways in A549 lung cancer cells. Therefore, 18β-Gly is a novel promising candidate for the treatment of lung cancer. Keywords: 18β-glycyrrhetinic acid, lung cancer, apoptosis, cell cycle arrest, ROS, cell migration Lung cancer is one of the most common malignant tumors, with a morbidity and mortality that has rapidly increased globally in recent decades. 1 Despite advances in early detection and treatment strategies for lung cancer, the 5-year survival rate is still below 20%. 2 Treatment options for lung cancer included surgery, chemotherapy, radiation therapy, or a combination. In addition, systemic chemotherapy is commonly used to treat advanced lung cancer by controlling symptoms and prolonging survival. 3 Despite improved chemotherapy, long-term survival in patients with advanced lung cancer remains low. 4 Therefore, it is important to study the pathogenesis and molecular mechanisms of lung cancer, and to identify novel therapeutic drugs with high anti-cancer efficacy and few side effects. In recent years, natural compounds derived from traditional Chinese medicines have become a research hotspot in the development of highly effective anti-cancer drugs with few side effects. 5,6 18β-glycyrrhetinic acid (18β-Gly) is the major bioactive component of Glycyrrhizae Radix, possessing antiulcerative, anti-inflammatory, and antiproliferative properties. 7–9 In addition, 18β-Gly inhibits migration and invasion via the reactive oxygen species (ROS)/protein kinase C-alpha/ERK pathways in human gastric cancer cells. 10 However, to date, the effects of 18β-Gly on lung cancer remain unclear. ROS, mainly produced by mitochondria, play an important role in various signaling pathways. 11 Most research has focused on the regulatory relationship between ROS and downstream signaling pathways. 12,13 Mitogen-activated protein kinase (MAPK) and p53 are two important downstream molecules regulated by ROS, and are involved i -Abstract Truncated-

oncology,biotechnology & applied microbiology
Deletions that reveal recessive genes.

D. Coman,R. Gardner

European Journal of Human Genetics

Abstract:
Regulatory mechanism of α-hederin upon cisplatin sensibility in NSCLC at safe dose by destroying GSS/GSH/GPX2 axis–mediated glutathione oxidation-reduction system

Yue Wu,Dongliang Wang,Yuqing Lou,Xiyu Liu,Pinzheng Huang,Mingming Jin,Gang Huang

DOI: https://doi.org/10.1016/j.biopha.2022.112927

2022-06-01

Abstract:Emerging studies showed that α-hederin induced autophagic cell death in different cancers via reactive oxygen species. Nevertheless, α-hederin role in non-small-cell lung cancer (NSCLC) remains unknown. So, the aim of this study was to explain whether ferroptosis is a therapeutic strategy to NSCLC, and to explore the effect of α-hederin on NSCLC ferroptosis. Current investigation found that α-hederin inhibited NSCLC cell proliferation, invasion, and migration in vitro and in vivo at toxic doses. The α-hederin treatment also increased NSCLC cell chemosensitivity to cisplatin and promoted ferroptosis and apoptosis at a safe dose. Proteomics, metabolomics, and high-throughput sequencing detection confirmed that α-hederin treatment downregulated glutathione peroxidase 2 (GPX2), and glutathione synthase (GSS) expression suppressed the synthesis of glutathione (GSH), which destroyed the GSH redox system. Eventually, it led to ferroptosis, apoptosis, and membrane permeabilization in NSCLC. Taken together, the study provided molecular data to confirm that α-hederin induced ferroptosis, apoptosis, and membrane permeabilization in NSCLC by destroying the GSS/GSH/GPX2 axis–mediated GSH oxidation-reduction system at a safe and low-toxicity dose.

pharmacology & pharmacy,medicine, research & experimental
Pelargonidin inhibits cell growth and promotes oxidative stress‐mediated apoptosis in lung cancer A549 cells

Liwei Yue,Ying Li,Yuting Luo,Abdullah A. Alarfaj,Yubo Shi

DOI: https://doi.org/10.1002/bab.2621

2024-06-11

Biotechnology and Applied Biochemistry

Abstract:Lung cancer has the worst prognosis with an average 5‐year survival rate of only 10%–20%. Lung cancer has the highest prevalence rate and a second most common cause of cancer‐associated mortalities worldwide. The present study was planned to explore the anticancer effects of pelargonidin against the lung cancer A549 cells via analyzing oxidative stress‐mediated apoptosis. The viability of both control and pelargonidin‐treated A549 cells was analyzed using the MTT cytotoxicity assay at different time periods. The levels of endogenous ROS generation, mitochondrial membrane potential (Δψm), and apoptosis were assessed using corresponding fluorescent staining assays. The levels of oxidative stress biomarkers, including TBARS, SOD, CAT, and GSH, in the cell lysates of control and pelargonidin‐treated A549 cells were examined using the assay kits. The pelargonidin treatment substantially suppressed the A549 cell growth. Further, pelargonidin promoted the ROS production and depleted the Δψm levels in the A549 cells. The fluorescent staining assays witnessed the occurrence of increased apoptosis in the pelargonidin‐treated A549 cells. The pelargonidin also boosted the TBARS and reduced the antioxidant levels thereby promoted the oxidative stress‐regulated apoptosis in the A549 cells. In summary, the findings' results of the current study demonstrated an anticancer activity of pelargonidin on A549 cells. The pelargonidin treatment substantially decreased the growth and encouraged the oxidative stress‐regulated apoptosis in A549 cells. Therefore, it was evident that the pelargonidin could be employed as an effective anticancer candidate to treat the lung cancer.

biotechnology & applied microbiology,biochemistry & molecular biology
Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition

Cheng-Chin Chung,Tung-Yung Huang,Hung-Ru Chu,Roberto De Luca,Elena Candelotti,Chi-Hung Huang,Yu-Chen S H Yang,Sandra Incerpi,Jens Z Pedersen,Chi-Yu Lin,Haw-Ming Huang,Sheng-Yang Lee,Zi-Lin Li,Chun A ChangOu,Wen-Shan Li,Paul J Davis,Hung-Yun Lin,Jacqueline Whang-Peng,Kuan Wang,Yu-Chen S.H. Yang,Jens Z. Pedersen,Chun A. ChangOu,Paul J. Davis

DOI: https://doi.org/10.1016/j.fct.2022.112850

IF: 4.3

2022-03-01

Food and Chemical Toxicology

Abstract:The most common cancer, lung cancer, causes deaths worldwide. Most lung cancer patients have non-small cell lung carcinomas (NSCLCs) with a poor prognosis. The chemotherapies frequently cause resistance therefore search for new effective drugs for NSCLC patients is an urgent and essential issue. Deaminated thyroxine, tetraiodothyroacetic acid (tetrac), and its nano-analogue (NDAT) exhibit antiproliferative properties in several types of cancers. On the other hand, the most abundant secondary metabolite in the sponge Hippospongia sp., heteronemin, shows effective cytotoxic activity against different types of cancer cells. In the current study, we investigated the anticancer effects of heteronemin against two NSCLC cell lines, A549 and H1299 cells in vitro. Combined treatment with heteronemin and tetrac derivatives synergistically inhibited cancer cell growth and significantly modulated the ERK1/2 and STAT3 pathways in A549 cells but only ERK1/2 in H1299 cells. The combination treatments induce apoptosis via the caspases pathway in A549 cells but promote cell cycle arrest via CCND1 and PCNA inhibition in H1299 cells. In summary, these results suggest that combined treatment with heteronemin and tetrac derivatives could suppress signal transduction pathways essential for NSCLC cell growth. The synergetic effects can be used potentially as a therapeutic procedure for NSCLC patients.

toxicology,food science & technology

Exercise prescription for autistic populations

Synthesis and Antitumor Activity of Hederagenin Derivatives

Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Hederagenin promotes lung cancer cell death by activating CHAC1-dependent ferroptosis pathway

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Ethyl acetate extract from Selaginella doederleinii Hieron inhibits the growth of human lung cancer cells A549 via caspase-dependent apoptosis pathway

Alpha-Hederin induces incomplete autophagic injury in non-small cell lung cancer by interfering with the lysosomal acidification

Molecular mechanism of α-Hederin in tumor progression

Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

Huaier shows anti‐cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF‐1α pathway

Evaluation of the antiproliferative activity of 106 marine microbial metabolites against human lung cancer cells and potential antiproliferative mechanism of purpuride G

Rat brain aryl acylamidase: further characterization of multiple forms.

Dehydroevodiamine Targeting ACHE and ALDH3A1 Regulate Glycolytic Metabolism to Inhibit Hepatocellular Carcinoma Cell Apoptosis

Echocardiographic frequency and severity of aortic regurgitation after ultrasonic aortic valve debridement for aortic stenosis in persons aged greater than 65 years.

Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo

[Cytokine combinations for in vivo and ex vivo expansion of hematopoietic progenitor cells].

18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells

Deletions that reveal recessive genes.

Regulatory mechanism of α-hederin upon cisplatin sensibility in NSCLC at safe dose by destroying GSS/GSH/GPX2 axis–mediated glutathione oxidation-reduction system

Pelargonidin inhibits cell growth and promotes oxidative stress‐mediated apoptosis in lung cancer A549 cells

Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition